Document is current
Any future updates will be listed below
-
Authors
Wan, Wenze
Li, Yuan
Sun, Wentao
Cheng, Zewei
Ma, Fen
Shen, Sheng
Liu, Houbao
Zhang, Jiwei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82272772, 81872352, 82072682, 82173106, 82130115, 82272772, 81872352, 82072682, 82173106, 82130115, 82272772, 81872352, 82072682, 82173106, 82130115)
Natural Science Foundation of Shanghai (21ZR1459100, 21ZR1459100)
Science and Technology Commission of Shanghai Municipality (20DZ2254500, 20DZ2254500)
Shanghai Pujiang Program (20PJ1413000)
- License Information
-
More Information
Article History
Received: 25 February 2025
Accepted: 8 June 2025
First Online: 18 June 2025
Declarations
:
: The animal research was approved by the Institutional Animal Care and Use Committee of Shanghai Immunocan Biotechnology Co., Ltd (Approval Number: YMNK-AUA-01201, Approval Date: February 17th, 2023). The human research was approved by the Clinical Research Ethics Committee of Fudan University Zhongshan Hospital (Approval Number: B2023-299R2, Approval Date: December 11, 2023). Additionally, it should be noted that at our teaching hospital, all patients admitted for surgical procedures are required to sign consent forms allowing for the use of their surgical specimens for research purposes. Therefore, research involving surgical specimens is exempt from the requirement for explicit informed consent.
: All authors have agreed with publishing this manuscript.
: The authors declare no competing interests.
